NCT02966652 - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

October 4, 2018

Study Completion Date

October 4, 2018

Conditions

Male Hypogonadism

Interventions

DRUG

DITEST

Lipid formulation of native oral testosterone.

DRUG

Testosterone undecanoate

Generic treatment for patients with primary or secondary male hypogonadism

Trial Locations (1)

Sheffield Teaching Hospital - Royal Hallamshire Hospital, Sheffield